176 related articles for article (PubMed ID: 27214087)
1. Significant natriuretic and antihypertensive action of the epithelial sodium channel blocker amiloride in diabetic patients with and without nephropathy.
Andersen H; Hansen PB; Bistrup C; Nielsen F; Henriksen JE; Jensen BL
J Hypertens; 2016 Aug; 34(8):1621-9. PubMed ID: 27214087
[TBL] [Abstract][Full Text] [Related]
2. Diabetic nephropathy is associated with increased urine excretion of proteases plasmin, prostasin and urokinase and activation of amiloride-sensitive current in collecting duct cells.
Andersen H; Friis UG; Hansen PB; Svenningsen P; Henriksen JE; Jensen BL
Nephrol Dial Transplant; 2015 May; 30(5):781-9. PubMed ID: 25609736
[TBL] [Abstract][Full Text] [Related]
3. Amiloride evokes significant natriuresis and weight loss in kidney transplant recipients with and without albuminuria.
Hinrichs GR; Nielsen JR; Birn H; Bistrup C; Jensen BL
Am J Physiol Renal Physiol; 2023 Oct; 325(4):F426-F435. PubMed ID: 37560772
[TBL] [Abstract][Full Text] [Related]
4. Plasminogen Deficiency and Amiloride Mitigate Angiotensin II-Induced Hypertension in Type 1 Diabetic Mice Suggesting Effects Through the Epithelial Sodium Channel.
Andersen H; Hansen MH; Buhl KB; Stæhr M; Friis UG; Enggaard C; Supramaniyam S; Lund IK; Svenningsen P; Hansen PBL; Jensen BL
J Am Heart Assoc; 2020 Dec; 9(23):e016387. PubMed ID: 33215566
[TBL] [Abstract][Full Text] [Related]
5. Amiloride lowers blood pressure and attenuates urine plasminogen activation in patients with treatment-resistant hypertension.
Oxlund CS; Buhl KB; Jacobsen IA; Hansen MR; Gram J; Henriksen JE; Schousboe K; Tarnow L; Jensen BL
J Am Soc Hypertens; 2014 Dec; 8(12):872-81. PubMed ID: 25492830
[TBL] [Abstract][Full Text] [Related]
6. Aberrant glomerular filtration of urokinase-type plasminogen activator in nephrotic syndrome leads to amiloride-sensitive plasminogen activation in urine.
Stæhr M; Buhl KB; Andersen RF; Svenningsen P; Nielsen F; Hinrichs GR; Bistrup C; Jensen BL
Am J Physiol Renal Physiol; 2015 Aug; 309(3):F235-41. PubMed ID: 25972510
[TBL] [Abstract][Full Text] [Related]
7. Urokinase-type plasminogen activator contributes to amiloride-sensitive sodium retention in nephrotic range glomerular proteinuria in mice.
Hinrichs GR; Weyer K; Friis UG; Svenningsen P; Lund IK; Nielsen R; Mollet G; Antignac C; Bistrup C; Jensen BL; Birn H
Acta Physiol (Oxf); 2019 Dec; 227(4):e13362. PubMed ID: 31423748
[TBL] [Abstract][Full Text] [Related]
8. Urinary serine proteases and activation of ENaC in kidney--implications for physiological renal salt handling and hypertensive disorders with albuminuria.
Svenningsen P; Andersen H; Nielsen LH; Jensen BL
Pflugers Arch; 2015 Mar; 467(3):531-42. PubMed ID: 25482671
[TBL] [Abstract][Full Text] [Related]
9. Plasmin in urine from patients with type 2 diabetes and treatment-resistant hypertension activates ENaC in vitro.
Buhl KB; Oxlund CS; Friis UG; Svenningsen P; Bistrup C; Jacobsen IA; Jensen BL
J Hypertens; 2014 Aug; 32(8):1672-7; discussion 1677. PubMed ID: 24805959
[TBL] [Abstract][Full Text] [Related]
10. [Regulation of natriuresis in diabetic nephropathy].
Późniak J
Ann Acad Med Stetin; 2000; 46():241-52. PubMed ID: 11712308
[TBL] [Abstract][Full Text] [Related]
11. Effects of dietary sodium on blood pressure in IDDM patients with nephropathy.
Mühlhauser I; Prange K; Sawicki PT; Bender R; Dworschak A; Schaden W; Berger M
Diabetologia; 1996 Feb; 39(2):212-9. PubMed ID: 8635674
[TBL] [Abstract][Full Text] [Related]
12. Basal and stimulated plasma atrial natriuretic factor in patients with type 1 diabetes with and without nephropathy.
McKnight JA; Roberts G; Sheridan B; Bell PM; Atkinson AB
Diabet Med; 1991 Oct; 8(8):765-9. PubMed ID: 1838069
[TBL] [Abstract][Full Text] [Related]
13. Epithelial sodium channel blockade and new β-ENaC polymorphisms among normotensive and hypertensive adult Nigerians.
Elias SO; Sofola OA; Jaja SI
Clin Exp Hypertens; 2019; 41(2):144-151. PubMed ID: 29580127
[TBL] [Abstract][Full Text] [Related]
14. Urine albumin is a superior predictor of preeclampsia compared to urine plasminogen in type I diabetes patients.
Nielsen LH; Jensen BL; Fuglsang J; Andersen LLT; Jensen DM; Jørgensen JS; Kitlen G; Ovesen P
J Am Soc Hypertens; 2018 Feb; 12(2):97-107. PubMed ID: 29305116
[TBL] [Abstract][Full Text] [Related]
15. Renal tubule angiotensin II type 1 receptor-associated protein promotes natriuresis and inhibits salt-sensitive blood pressure elevation.
Wakui H; Uneda K; Tamura K; Ohsawa M; Azushima K; Kobayashi R; Ohki K; Dejima T; Kanaoka T; Tsurumi-Ikeya Y; Matsuda M; Haruhara K; Nishiyama A; Yabana M; Fujikawa T; Yamashita A; Umemura S
J Am Heart Assoc; 2015 Mar; 4(3):e001594. PubMed ID: 25792129
[TBL] [Abstract][Full Text] [Related]
16. Low-protein diet and kidney function in insulin-dependent diabetic patients with diabetic nephropathy.
Hansen HP; Christensen PK; Tauber-Lassen E; Klausen A; Jensen BR; Parving HH
Kidney Int; 1999 Feb; 55(2):621-8. PubMed ID: 9987086
[TBL] [Abstract][Full Text] [Related]
17. Remission of nephrotic syndrome diminishes urinary plasmin content and abolishes activation of ENaC.
Andersen RF; Buhl KB; Jensen BL; Svenningsen P; Friis UG; Jespersen B; Rittig S
Pediatr Nephrol; 2013 Aug; 28(8):1227-34. PubMed ID: 23503750
[TBL] [Abstract][Full Text] [Related]
18. Short-term treatment with ramipril normalizes renal haemodynamics and the natriuretic response to a sodium load in type 1 diabetic patients with early nephropathy.
Stenvinkel P; Bolinder J; Alvestrand A
Acta Diabetol; 1997 Mar; 34(1):10-7. PubMed ID: 9134051
[TBL] [Abstract][Full Text] [Related]
19. Amiloride Reduces Urokinase/Plasminogen-Driven Intratubular Complement Activation in Glomerular Proteinuria.
Isaksson GL; Hinrichs GR; Andersen H; Bach ML; Weyer K; Zachar R; Henriksen JE; Madsen K; Lund IK; Mollet G; Bistrup C; Birn H; Jensen BL; Palarasah Y
J Am Soc Nephrol; 2024 Apr; 35(4):410-425. PubMed ID: 38254266
[TBL] [Abstract][Full Text] [Related]
20. Effects of sodium intake on albumin excretion in patients with diabetic nephropathy treated with long-acting calcium antagonists.
Bakris GL; Smith A
Ann Intern Med; 1996 Aug; 125(3):201-4. PubMed ID: 8686978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
